{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:46Z","timestamp":1707524506657},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,27]]},"DOI":"10.7759\/cureus.20732","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T11:12:16Z","timestamp":1640603536000},"source":"Crossref","is-referenced-by-count":0,"title":["A Cross-Sectional Study of the Current Management of Hypertriglyceridemia"],"prefix":"10.7759","author":[{"given":"Raghad A","family":"Jar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ealaf","family":"Melibari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidaa","family":"Almehmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renad  O","family":"Kalantan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulhalim J","family":"Kinsara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2011.10.002","article-title":"Serum triglycerides and risk of cardiovascular disease","volume":"1821","author":"Boullart AC","year":"2012","unstructured":"Boullart AC, de Graaf J, Stalenhoef AF. Serum triglycerides and risk of cardiovascular disease. Biochim Biophys Acta. 2012, 1821:867-75. 10.1016\/j.bbalip.2011.10.002","journal-title":"Biochim Biophys Acta"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.NPR.0000544997.22887.0b","article-title":"Hypertriglyceridemia: a review of the evidence","volume":"43","author":"Elkins C","year":"2018","unstructured":"Elkins C, Friedrich D. Hypertriglyceridemia: a review of the evidence. Nurse Pract. 2018, 43:22-9. 10.1097\/01.NPR.0000544997.22887.0b","journal-title":"Nurse Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0625-0","article-title":"Hypertriglyceridemia and atherosclerosis","volume":"16","author":"Peng J","year":"2017","unstructured":"Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis. 2017, 16:233. 10.1186\/s12944-017-0625-0","journal-title":"Lipids Health Dis"},{"key":"ref4","article-title":"Hyperlipidemia in Saudi Arabia","volume":"29","author":"Al-Nozha MM","year":"2008","unstructured":"Al-Nozha MM, Arafah MR, Al-Maatouq MA, et al.. Hyperlipidemia in Saudi Arabia. Saudi Med J. 2008, 29:282-7.","journal-title":"Saudi Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111642","article-title":"Impact of circulating triglycerides concentration on atherosclerotic disease status in middle-aged Saudi Arabian dwellers","volume":"10","author":"Azhar W","year":"2018","unstructured":"Azhar W, Buczkowski B, Smith C, Onambele-Pearson G. Impact of circulating triglycerides concentration on atherosclerotic disease status in middle-aged Saudi Arabian dwellers. Nutrients. 2018, 10:10.3390\/nu10111642","journal-title":"Nutrients"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller M","year":"2011","unstructured":"Miller M, Stone NJ, Ballantyne C, et al.. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011, 123:2292-333. 10.1161\/CIR.0b013e3182160726","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference BA","year":"2019","unstructured":"Ference BA, Kastelein JJ, Ray KK, et al.. Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. JAMA. 2019, 321:364-73. 10.1001\/jama.2018.20045","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar N","year":"2010","unstructured":"Sarwar N, Sandhu MS, Ricketts SL, et al.. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010, 375:1634-9. 10.1016\/S0140-6736(10)60545-4","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012415","article-title":"association of metabolic syndrome and its components with risk of stroke recurrence and mortality: a meta-analysis","volume":"97","author":"Zhang F","year":"2021","unstructured":"Zhang F, Liu L, Zhang C, Ji S, Mei Z, Li T. association of metabolic syndrome and its components with risk of stroke recurrence and mortality: a meta-analysis. Neurology. 2021, 97:e695-705. 10.1212\/WNL.0000000000012415","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.6571","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio E","year":"2012","unstructured":"Di Angelantonio E, Gao P, Pennells L, et al.. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012, 307:2499-506. 10.1001\/jama.2012.6571","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.13985","article-title":"association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman MG","year":"2016","unstructured":"Silverman MG, Ference BA, Im K, et al.. association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA. 2016, 316:1289-97. 10.1001\/jama.2016.13985","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008491","article-title":"Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: a meta-analysis of prospective cohort studies","volume":"96","author":"Ju SY","year":"2017","unstructured":"Ju SY, Lee JY, Kim DH. Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: a meta-analysis of prospective cohort studies. Medicine (Baltimore). 2017, 96:e8491. 10.1097\/MD.0000000000008491","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R082271","article-title":"Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding","volume":"59","author":"Sniderman AD","year":"2018","unstructured":"Sniderman AD, Couture P, Martin SS, et al.. Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding. J Lipid Res. 2018, 59:1266-75. 10.1194\/jlr.R082271","journal-title":"J Lipid Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal S","year":"2007","unstructured":"Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007, 298:309-16. 10.1001\/jama.298.3.309","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2013.12.011","article-title":"Prevalence of dyslipidemia and associated risk factors in Turkish adults","volume":"8","author":"Bayram F","year":"2014","unstructured":"Bayram F, Kocer D, Gundogan K, et al.. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol. 2014, 8:206-16. 10.1016\/j.jacl.2013.12.011","journal-title":"J Clin Lipidol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-54492011000200007","article-title":"Association of lipids with coronary heart disease in a Saudi population","volume":"10","author":"Ashmaig ME","year":"2011","unstructured":"Ashmaig ME, Ashmeik K, Ahmed A, et al.. Association of lipids with coronary heart disease in a Saudi population. J Vasc Bras. 2011, 10:131-6. 10.1590\/S1677-54492011000200007","journal-title":"J Vasc Bras"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000511065","article-title":"Acute myocardial infarction complicated by very severe hypertriglyceridemia","volume":"3","author":"Wu G","year":"2020","unstructured":"Wu G, Bockman B, Perez J. Acute myocardial infarction complicated by very severe hypertriglyceridemia. Case Rep Acute Med. 2020, 3:79-82. 10.1159\/000511065","journal-title":"Case Rep Acute Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-1243","article-title":"A systematic review and meta-analysis on the efficacy of statins in the treatment of atherosclerosis","volume":"10","author":"Jia J","year":"2021","unstructured":"Jia J, Zhang L, Wang L, Ji C, Xia R, Yang Y. A systematic review and meta-analysis on the efficacy of statins in the treatment of atherosclerosis. Ann Palliat Med. 2021, 10:6793-803. 10.21037\/apm-21-1243","journal-title":"Ann Palliat Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","unstructured":"2019 ESC\/EAS guidelines for the management of dyslipidaemias. lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019, 290:140-205. 10.1016\/j.atherosclerosis.2019.08.014","journal-title":"Atherosclerosis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2021.09.006","article-title":"Community-based cardiovascular disease prevention programmes and cardiovascular risk factors: a systematic review and meta-analysis","volume":"200","author":"Soltani S","year":"2021","unstructured":"Soltani S, Saraf-Bank S, Basirat R, et al.. Community-based cardiovascular disease prevention programmes and cardiovascular risk factors: a systematic review and meta-analysis. Public Health. 2021, 200:59-70. 10.1016\/j.puhe.2021.09.006","journal-title":"Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80780-a-cross-sectional-study-of-the-current-management-of-hypertriglyceridemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:12Z","timestamp":1707507072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80780-a-cross-sectional-study-of-the-current-management-of-hypertriglyceridemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.20732","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,27]]}}}